| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Divisions of Cardiovascular Research (R.J.D., M.B., A.H., G.J.W.) and Pathology (G.J.W.), Research Institute, The Hospital for Sick Children; the Departments of Physiology (H.C.C., M.B., P.H.B., G.J.W.) and Medicine (P.H.B.), The University of Toronto; and the Division of Cardiology (C. Z., P.H.B.), University Health Network, Toronto, Canada. Present address of C.Z. is Laboratory of Muscle Research and Molecular Cardiology, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany.
Correspondence to Dr Gregory J. Wilson, Division of Cardiovascular Research, McMaster Bldg, Rm 7019C, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada. E-mail Diazport{at}sickkids.ca
Volume regulatory Cl channels are key regulators of ischemic preconditioning (IPC). Because Cl efflux must be balanced by an efflux of cations to maintain cell membrane electroneutrality during volume regulation, we hypothesize that IK1 channels may play a role in IPC. We subjected cultured cardiomyocytes to 60-minute simulated ischemia (SI) followed by 60-minute of simulated reperfusion (SR) and assessed percent cell death using trypan blue staining. Ischemic preconditioning (10-minute SI/10-minute SR) significantly (P<0.0001) reduced the percent cell death in nontransfected cardiomyocytes [IPCCM 18.0±2.1% versus control (CCM) 48.3±1.0%]. IPC protection was not altered by overexpression of the reporter gene (enhanced green fluorescent protein, EGFP). However, overexpression of dominant-negative Kir2.1 or Kir2.2 genes using adenoviruses (AdEGFPKir2.1DN or AdEGFPKir2.2DN) encoding the reporter gene EGFP prevented IPC protection [both IPCCM+AdEGFPKir2.1DN 45.8±2.3% (mean±SEM) and IPCCM+AdEGFPKir2.2DN 47.9±1.4% versus IPCCM; P<0.0001] in cultured cardiomyocytes (n=8 hearts). Transfection of cardiomyocytes with AdEGFPKir2.1DN or AdEGFPKir2.2DN did not affect cell death in control (nonpreconditioned) cardiomyocytes (both CCM+ AdEGFPKir2.1DN 45.8±0.7% and CCM+AdEGFPKir2.2DN 46.2±1.3% versus CCM; not statistically significant). Similar effects were observed in both cultured (n=5 hearts) and freshly isolated (n=4 hearts) ventricular cardiomyocytes after IK1 blockade with 20 µmol/L BaCl2 plus 1 µmol/L nifedipine (to prevent Ba2+ uptake). Nifedipine alone neither protected against ischemic injury nor blocked IPC protection. Our findings establish that IK1 channels play an important role in IPC protection.
Key Words: ischemic preconditioning cardiomyocytes ischemia potassium channels gene transfer
This article has been cited by other articles:
![]() |
Y. Lu, Y. Zhang, H. Shan, Z. Pan, X. Li, B. Li, C. Xu, B. Zhang, F. Zhang, D. Dong, et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection Cardiovasc Res, December 1, 2009; 84(3): 434 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Chen, T. E. Callis, and D.-Z. Wang microRNAs and muscle disorders J. Cell Sci., January 1, 2009; 122(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yang, Y. Lu, and Z. Wang Control of cardiac excitability by microRNAs Cardiovasc Res, September 1, 2008; 79(4): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, N. Honbo, E. J. Goetzl, K. Chatterjee, J. S. Karliner, and M. O. Gray Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3150 - H3158. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Z. Mei, H.-J. Mao, and L.-H. Jiang Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1022 - C1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Diaz and G. J. Wilson Studying ischemic preconditioning in isolated cardiomyocyte models Cardiovasc Res, May 1, 2006; 70(2): 286 - 296. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |